Prevention of preterm delivery after successful tocolysis in preterm labour by 17 alpha-hydroxyprogesterone caproate: a randomised controlled trial

被引:0
|
作者
Rozenberg, Patrick [1 ]
Deruelle, Philippe [2 ]
Chauveaud, Aurelia [3 ]
Capelle, Marianne [4 ]
Winer, Norbert [5 ]
Porcher, Raphael [6 ]
Azria, Elie [7 ,8 ]
机构
[1] Poissy St Germain Hosp, Poissy, France
[2] Univ Lille 2, EA 4489, Lille, France
[3] Antoine Bclre Hosp, AP HP, Clamart, France
[4] La Concept Hosp, Marseille, France
[5] Mre Enfant Hosp, Nantes, France
[6] Paris Diderot Univ, St Louis Hosp, AP HP, Dept Biostat,UMR S717, Paris, France
[7] INSERM, Paris, France
[8] Cochin Port Royal St Vincent Paul Hosp, AP HP, Paris, France
关键词
D O I
10.1016/j.ajog.2011.10.029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
3
引用
收藏
页码:S2 / S3
页数:2
相关论文
共 50 条
  • [31] The Effectiveness of 17α-Hydroxyprogesterone Caproate in Obese Women for Prevention of Preterm Delivery
    Ngai, Ivan
    Marji, Melissa
    Neto, Nicole
    Garretto, Diana
    Sheen, Jean-Ju
    Garry, David J.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 161S - 162S
  • [32] Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
    Price, Joan T.
    Vwalika, Bellington
    Freeman, Bethany L.
    Cole, Stephen R.
    Saha, Pooja T.
    Mbewe, Felistas M.
    Phiri, Winifreda M.
    Peterson, Marc
    Muyangwa, Dorothy
    Sindano, Ntazana
    Mwape, Humphrey
    Smithmyer, Megan E.
    Kasaro, Margaret P.
    Rouse, Dwight J.
    Goldenberg, Robert L.
    Chomba, Elwyn
    Stringer, Jeffrey S. A.
    LANCET HIV, 2021, 8 (10): : E605 - E613
  • [33] Smoking and preterm birth: A novel effect of 17 alpha-hydroxyprogesterone caproate (17OHP-C)
    Heyborne, Kent
    Allshouse, Amanda A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S220 - S221
  • [34] A Double-Blind, Randomized, Placebo-Controlled Trial of 17 Alpha-hydroxyprogesterone Caproate in the Management of Preterm Premature Rupture of Membranes
    Langen, Elizabeth S.
    Sit, Anita
    Sherwin, Katie
    Lyell, Deirdre J.
    Blumenfeld, Yair J.
    El-Sayed, Yasser Y.
    AMERICAN JOURNAL OF PERINATOLOGY, 2018, 35 (08) : 779 - 784
  • [35] 17 α-Hydroxyprogesterone Caproate (Makena™)In the Prevention of Preterm Birth
    Emma D. Deeks
    Pediatric Drugs, 2011, 13 : 337 - 345
  • [36] The impact of prior gestational age at preterm delivery on the effectiveness of 17 alpha-hydroxyprogesterone caproate (17OHPC) in clinical practice
    Quintero, Victor Hugo Gonzalez
    de la Torre, Lesley
    Istwan, Niki
    Rhea, Debbie
    Tudela, Carmen Maria
    Vazquez-Vera, Enrique
    Stanziano, Gary
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S57 - S57
  • [37] 17 α-Hydroxyprogesterone Caproate (Makena™) In the Prevention of Preterm Birth
    Deeks, Emma D.
    PEDIATRIC DRUGS, 2011, 13 (05) : 337 - 345
  • [38] Effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alpha-hydroxyprogesterone caproate injections
    Haidar, Ziad A.
    Moussa, Hind N.
    Hosseini Nasab, Susan
    Sibai, Baha M.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2017, 30 (24): : 2926 - 2932
  • [39] The effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alpha-hydroxyprogesterone caproate injections
    Haidar, Ziad A.
    Moussa, Hind N.
    Sibai, Baha M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S288 - S288
  • [40] 17α-hydroxyprogesterone caproate for the prevention of preterm delivery -: A cost-effectiveness analysis
    Odibo, Anthony O.
    Stamilio, David M.
    Macones, George A.
    Polsky, Daniel
    OBSTETRICS AND GYNECOLOGY, 2006, 108 (03): : 492 - 499